Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer
程序性死亡配体1表达对非肌层浸润性膀胱癌经尿道切除术后OK-432免疫治疗的影响
期刊:Oncology Letters
影响因子:2.5
doi:10.3892/ol.2017.6080
Zhi-Hua Liu, Fu-Fu Zheng, Yu-Ling Mao, Lie-Fu Ye, Jun Bian, De-Hui Lai, Yun-Lin Ye, Yu-Ping Dai
